摘要
目的对复方卡托普利片中新发现的未知杂质进行来源分析和结构的初步确认,以期为该制剂改进工艺和提高标准提供依据。方法采用Kromasil苯基色谱柱(250 mm×4.6 mm,5μm),以水-磷酸(550︰0.5)和甲醇为流动相进行梯度洗脱,检测波长为210 nm。对市售的复方卡托普利片中的该未知杂质的含量进行系统的评价;同时采用液质联用的方法对该未知杂质的结构进行确认。结果该未知杂质为复方制剂的2种原料卡托普利和氢氯噻嗪在受热过程中产生的二聚物,分子式为C16H23N4O7S3Cl;市售产品多数含有该杂质。结论本研究为复方卡托普利片的质量控制和工艺优化提供了参考依据。
OBJECTIVE To improve the quality and provide technological support for reducing the impurity content of Compound Captopril tablet, the source and structure determination of the unknown-impurity is studied. METHODS A Kromasil Phenyl column（250 mm×4.6 mm, 5 μm） was used. The wavelength of UV detector was 210 nm. HPLC gradient elution was used with water-phosphoric acid（550︰0.5） and methanol as mobile phase to find the source and determine the content of the unknown impurity in Compound Captopril tablets. The structure of the unknown impurity was identified by LC-MS. RESULTS The unknown impurity was elucidated as C16 H23 N4 O7 S3 Cl, which was the dipolymer of hydrochlorothiazide and captopril by heating, and was included in most of the domestic generic Compound Captopril tablet. CONCLUSION This study provides reference for the improvement of quality control and process optimization of Compound Captopril tablet.
作者
林丽琴
杨直
彭彦
LIN Liqin;YANG Zhi;PENG Yan(Hangzhou Institute for Food and Drug Control,Hangzhou 310022,China)
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2018年第10期1471-1475,共5页
Chinese Journal of Modern Applied Pharmacy
